N/A N=105 Effects of Fast Bar on Physiological Fasting
Fasting
Primary: Ketone Area Under the Curve — 1.27; 0.62; 1.17 mg/dL*h
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=12 Evaluation of Computer-Aided Lung Nodule Detection Software in Thoracic CT for Riverain Technologies LLC
Lung Cancer
Primary: Comparing the Detection Accuracy, Sensitivity, and Specificity of Clinically Actionable Lung Nodules — 3612; 3735; 1283; 1548 CT-case | nodule — p=<0.05
N/A N=66 Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa
Human Immunodeficiency Virus · Alcohol-Related Disorders · Drug Use
Primary: Changes in HIV Medication Adherence Throughout Intervention Phase — 60.0; 28.2 percentage of days adherent to Wisepill — p=.01
Phase 2 N=30 Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)
Subarachnoid Hemorrhage, Aneurysmal
Primary: Number of Participants With Intracranial Hemorrhage (Symptomatic and Asymptomatic) — 2; 1 Participants
Phase 1 N=3 TL011 in Severe, Active Rheumatoid Arthritis Patients
Rheumatoid Arthritis
Primary: Area Under the Plasma Concentration Versus Time Curve [AUC(0-t)] in Part B — 7571; 8377 Day*micrograms per milliliter — p=0.4265
Phase 1 N=6 Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
Healthy Adult Participants
Primary: Mean Serum Concentrations (Cmax) for Open-label Palivizumab (Part 1) on Day 12. — 71.2 μg/mL
N/A N=54 Custom Cutting Block Instrument vs Regular Instrumentation Total Knee Replacement (TKR)
Osteoarthritis, Knee
Primary: Radiographic Alignment — -1.6; -1.8; 89.4; 89.3 degree — p=0.790
Phase 4 N=56 Postpartum HPV Vaccination
HPV-Related Malignancy
Primary: Patient Indication of Willingness to Accept the Vaccine Based on Survey — 56 Participants
Phase 1 N=6 Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male Participants
Healthy Volunteers
Primary: Period 1: Percent Absolute Bioavailability (%F) for TAK-935 — 12.57 percent absolute bioavailability
Phase 2 N=148 Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet
Transfusion-dependent Thalassemia · Non-transfusion-dependent Thalassemia
Primary: Number of Participants Preferring Deferasirox FCT or DT at Week 48 Based on Preference Questionnaire (Item 2) — 10; 121; 3 Participants — p=<.0001
Phase 4 N=31 The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Major Depressive Disorder
Primary: Change in Montgomery and Asberg Depression Rating Scale (MADRS) — 33.28; 16.23 score on a scale — p=<0.001
N/A N=110 Postoperative Pain Control for Prostatectomy
Prostate Cancer
Primary: Total Milligrams of Opiates — 5.15; 2.52 mg — p=0.0012
N/A N=763 Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Spondyloarthrosis
Primary: Percentage of Participants With 7 Years Adherence to Etanercept — 60.6 Percentage of participants
Phase 3 N=251 Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
Primary: Percentage of Participants Achieving A Clinical Response — 45; 22 Participants
N/A N=57 Tracking Physical Activity for Chronic Pain Management Among Older Adults in Detroit
Chronic Pain
Primary: Change in Pain Interference — -0.85; -0.21 score on a scale